Zobrazeno 1 - 4
of 4
pro vyhledávání: '"2020 World Conference on Lung Cancer"'
Autor:
Lamberts, Virginie, Aldea, Mihaela, Mezquita, Laura, Jovelet, Cécile, Vasseur, Damien, Aboubakar Nana, Frank, Remon, Jordy, Rouleau, Etienne, Lacroix, Ludovic, Ngo Camus, Maud, Nicotra, Claudio, Naltet, Charles, Lavaud, Pernelle, Gazzah, Anas, Besse, Benjamin, Planchard, David, 2020 World Conference on Lung Cancer
Publikováno v:
Journal of Thoracic Oncology, Vol. 16, no.3, p. S417 (2021)
INTRODUCTION : EGFR mutations occur in 15% of Caucasian and up to 50% of Asian patients with advanced NSCLC. Tissue genomic profiling is the gold standard but the liquid biopsy is a good surrogate of the tissue for molecular diagnosis. The digital dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1493::052a37958043efc6fc809dba68a06b28
https://hdl.handle.net/2078.1/245520
https://hdl.handle.net/2078.1/245520
Autor:
Vanderputten, Marie, Aboubakar Nana, Frank, Bouzin, Caroline, Hoton, Delphine, Stanciu Pop, Claudia Maria, Lecocq, Marylène, Ambroise, Jérôme, Pilette, Charles, Ocak, Sebahat, 2020 World Conference on Lung Cancer
Publikováno v:
Journal of Thoracic Oncology, Vol. 16, no.3, p. S569 (2021)
Introduction : Lung cancer is the most frequent and the deadliest cancer in the world. In non-small cell lung cancer (NSCLC), which represents 85% of all lung cancers, up to 55% patients relapse following surgery alone or in combination with chemothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1493::26cdcb3b1482b3d7fd1bf4939693ac90
https://hdl.handle.net/2078.1/245517
https://hdl.handle.net/2078.1/245517
Autor:
Riudavets, M., Mezquita, L., Auclin, E., Benitez, J.C., Le Pechoux, C., Majem, M., Dempsey, N., Lobefaro, R., Nadal, E., Amores, A., Menis, J., Tagliamento, M., López-Castro, R., Ponce, S., Bosch-Barrera, J., Aboubakar Nana, Frank, Mosquera, J., Pilotto, S., Reyes, R., Mielgo, X., Duchemann, B., Mosteiro, M., Mussat, E., De Giglio, A., Scheffler, M., Campayo, M., Botticella, A., Naltet, C., Lavaud, P., Lopes, G., Signorelli, D., Garcia-Campelo, R., Besse, B., Planchard, D., 2020 World Conference on Lung Cancer
Publikováno v:
Journal of Thoracic Oncology, Vol. 16, no.3, p. S161 (2021)
INTRODUCTION : The lung immune prognostic index (LIPI), which combines pretreatment derived neutrophils/[leukocytes minus neutrophils] ratio (dNLR) >3 and lactate dehydrogenase (LDH) > upper limit of normal (ULN), is associated with outcomes in advan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1493::d12bee7492698eef5a691517404466b0
https://hdl.handle.net/2078.1/245519
https://hdl.handle.net/2078.1/245519
Autor:
Blanc-Durand, F., Mielgo Rubio, X., Auclin, E., Ponce-Aix, S., Lopez Castro, R., Nadal, E., Planchard, D., Routy, B., Hendriks, L., Sullivan, I., Dempsey, N., Pilotto, S., Aboubakar Nana, Frank, Pinato, D.J., Castonguay, M., Rodriguez, A., Amores, A., Bluthgen, M.V., Duchemann, B., Castellano, P. Cruz, Aguado De La Rosa, C., Sereno Moyano, M., Ruffinelli, J., Lopez, G., Caramella, C., Besse, B., Mezquita, L., 2020 World Conference on Lung Cancer
Publikováno v:
Journal of Thoracic Oncology, Vol. 16, no.3, p. S205-S206 (2021)
INTRODUCTION : The Lung Immune Prognostic Index (LIPI) that combines the neutrophils/[leucocytes minus neutrophils] ratio (dNLR) and lactate dehydrogenase (LDH), is associated with outcomes in pretreated advanced NSCLC patients receiving single agent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1493::b2ea098b76d52935182911fb6232552f
https://hdl.handle.net/2078.1/245518
https://hdl.handle.net/2078.1/245518